PCPedro CahnMD, PhDVideoHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Starting HAART in 2019: When and How - Pedro Cahn, MD, PhDView Video
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Clinical case presentation: A preliminary profile of common co-morbidities and risk practices in a sample of HIV/HCV co-infected patients in Puerto RicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-USView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Implementation science for HIV prevention using an eHealth program for Spanish-speaking sexual minorities groups in Puerto RicoView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019High prevalence of hepatitis B virus infection among chronic kidney disease patientsView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Time to treatment disfavors patients living with HIV/HCV co-infectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Prevalence of alcohol and substance use in a sample of patients living with HIV/HCV co-infection who are in routine clinical care receiving antiretroviral therapyView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Efficacy and safety of sofosbuvir/velpatasvir for the treatment of patients with chronic hepatitis C genotype 1-6 infection: Integrated analysis of eight Phase 3 clinical trialsView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Heterogeneity in priorities for continuing education training among clinicians providing (or not!) HIV and HCV clinical servicesView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Automated electrochemiluminescence assay could be used for screening hepatitis B and C markers in dried blood spot samples?View Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 201996 Week efficacy and safety of B/F/TAF in treatment-naïve adults and adults ≥ 50 yearsView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePuerto Rico Meeting on Hepatitis & HIV 2019Tenofovir alafenamide vs tenofovir DF in women: Pooled analysis of 7 clinical trialsView Abstract
